Company Profile

Enveric Biosciences Stock Price, News & Catalysts

Ticker:
ENVB
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

1.41 USD (-1.40%)

Close

Last updated: August 24, 2026

8.17M USD

Market cap

Why the stock is moving

As of Aug 24, 2026, ENVB closed down 1.40% at $1.41. No new same-company headline was identified in the current news window.

Company overview

Business overview

Enveric Biosciences is a neuroscience company focused on next-generation psychedelic-inspired and other CNS therapies. Its story centers on mental-health biology and the search for differentiated neuropsychiatric treatments.

Geographic Base and Sector Classification

Enveric is headquartered in the United States and listed on NASDAQ. It sits in small-cap neuroscience biotechnology.

Business Model Characteristics

The company depends on preclinical and early clinical work, translational validation, and capital support. Investors usually watch platform updates, strategic focus, and the ability to maintain a coherent CNS thesis.

Position Within the Biotechnology Landscape

Enveric occupies a speculative neuroscience niche within biotech. It is a high-risk story where early platform proof matters a great deal.

Future catalysts

  • Enveric’s catalysts are psycho-oncology and CNS-related programs, plus any update that shows the platform can still generate value. The market remains early-stage and data-sensitive.

Recent news

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Enveric Biosciences (ENVB)?

    Enveric Biosciences (ENVB) most recently closed at 1.41 USD, a -1.40% move versus the previous session.

    What is the market cap of Enveric Biosciences (ENVB)?

    Enveric Biosciences currently has a market capitalization of 8.17M USD on BioPharmSignal.

    What does Enveric Biosciences do?

    Enveric Biosciences is a neuroscience company focused on next-generation psychedelic-inspired and other CNS therapies. Its story centers on mental-health biology and the search for differentiated neuropsychiatric treatments.

    On which exchange is ENVB stock listed?

    Enveric Biosciences (ENVB) is associated with NASDAQ, United States, Biopharma.

    What is Enveric?

    Enveric’s catalysts are psycho-oncology and CNS-related programs, plus any update that shows the platform can still generate value.

    Which conditions is Enveric Biosciences targeting with Enveric?

    Enveric Biosciences is associated with oncology, neuroscience based on its company overview and current catalyst commentary.

    How does Enveric Biosciences describe recent progress with Enveric?

    Enveric’s catalysts are psycho-oncology and CNS-related programs, plus any update that shows the platform can still generate value.

    What is Biosciences?

    Enveric Biosciences is a neuroscience company focused on next-generation psychedelic-inspired and other CNS therapies.